Results 181 to 190 of about 125,678 (274)

Data-driven characterization of distinct cognitive subtypes in Parkinson's disease dementia. [PDF]

open access: yesNPJ Parkinsons Dis
Labrador-Espinosa MA   +3 more
europepmc   +1 more source

Validation of the German Version of the Movement Disorder Society Non‐Motor Scale (MDS‐NMS)

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Jonas Bendig   +20 more
wiley   +1 more source

Hypotensive Episodes Precede Cognitive Fluctuations in Parkinson's Disease Dementia

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Cognitive fluctuations (CFs) are a disabling feature in Parkinson's disease dementia (PDD) and contribute to caregiver burden. The relationship between CFs and neurogenic orthostatic hypotension (nOH), a common autonomic complication in PDD, has not been adequately examined.
Jorge Patino   +6 more
wiley   +1 more source

Galantamine-Memantine Combination in the Treatment of Parkinson's Disease Dementia. [PDF]

open access: yesBrain Sci
Frost ED   +18 more
europepmc   +1 more source

Severe and Regionally Widespread Increases in Tissue Urea in the Human Brain Represent a Novel Finding of Pathogenic Potential in Parkinson's Disease Dementia. [PDF]

open access: yesFront Mol Neurosci, 2021
Scholefield M   +7 more
europepmc   +1 more source

Diagnostic Value of Bedside Eye Movement Examination in Movement Disorders

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Eloísa Bittencurt Thomaz de Assis   +4 more
wiley   +1 more source

Focused Ultrasound for the Treatment of Circuit and Molecular Pathology in Parkinson's Disease

open access: yesMovement Disorders, EarlyView.
Abstract Focused ultrasound is rapidly emerging as a novel technology for the development of symptomatic therapies and supporting disease‐modifying treatments for Parkinson's disease (PD). At the forefront of this development is thermoablation using high‐intensity focused ultrasound, an incisionless treatment that has been extensively tested in ...
Rikke Hahn Kofoed   +7 more
wiley   +1 more source

Pathogenic or Likely Pathogenic GRN Variants Are Found in 0.1% of Parkinson's Disease Patients

open access: yesMovement Disorders, EarlyView.
Abstract Background Parkinsonism may be observed in multiple neurodegenerative diseases, including GRN‐associated frontotemporal dementia (FTD‐GRN), complicating the differential diagnosis of Parkinson's disease (PD). Objectives To investigate the presence of GRN variants in a large group of PD patients.
Christian A. Ganoza   +31 more
wiley   +1 more source

Home - About - Disclaimer - Privacy